Correlation Between Science Technology and Delaware Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Science Technology and Delaware Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Science Technology and Delaware Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Science Technology Fund and Delaware Healthcare Fund, you can compare the effects of market volatilities on Science Technology and Delaware Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Science Technology with a short position of Delaware Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Science Technology and Delaware Healthcare.

Diversification Opportunities for Science Technology and Delaware Healthcare

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Science and Delaware is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Science Technology Fund and Delaware Healthcare Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Delaware Healthcare and Science Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Science Technology Fund are associated (or correlated) with Delaware Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Delaware Healthcare has no effect on the direction of Science Technology i.e., Science Technology and Delaware Healthcare go up and down completely randomly.

Pair Corralation between Science Technology and Delaware Healthcare

Assuming the 90 days horizon Science Technology Fund is expected to generate 0.76 times more return on investment than Delaware Healthcare. However, Science Technology Fund is 1.32 times less risky than Delaware Healthcare. It trades about 0.1 of its potential returns per unit of risk. Delaware Healthcare Fund is currently generating about -0.17 per unit of risk. If you would invest  2,691  in Science Technology Fund on October 23, 2024 and sell it today you would earn a total of  218.00  from holding Science Technology Fund or generate 8.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Science Technology Fund  vs.  Delaware Healthcare Fund

 Performance 
       Timeline  
Science Technology 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Science Technology Fund are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak fundamental indicators, Science Technology may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Delaware Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Delaware Healthcare Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's fundamental indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Science Technology and Delaware Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Science Technology and Delaware Healthcare

The main advantage of trading using opposite Science Technology and Delaware Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Science Technology position performs unexpectedly, Delaware Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Delaware Healthcare will offset losses from the drop in Delaware Healthcare's long position.
The idea behind Science Technology Fund and Delaware Healthcare Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance